WIPOSchützen Sie diese Marke vor Nachahmern!
Mit unserer Markenüberwachung werden Sie automatisch per E-Mail über Nachahmer und Trittbrettfahrer benachrichtigt.
Die Internationale Marke IQVIA wurde als Wortmarke am 02.10.2017 bei der Weltorganisation für geistiges Eigentum angemeldet.
| Markenform | Wortmarke |
| Aktenzeichen | 1419544 |
| Länder | 
|
| Basismarke |
Nr. 87436387,
04. Mai 2017
|
| Anmeldedatum | 02. Oktober 2017 |
| Ablaufdatum | 02. Oktober 2027 |
Markeninhaber
100 IMS Drive
Parsippany NJ 07054
US
Parsippany NJ 07054
US
Markenvertreter
PO Box 1022
Minneapolis MN 55440-1022
US
Waren und Dienstleistungen
09
Downloadable audio materials, audio-visual materials, video
materials, written materials, and visual materials in the
field of pharmaceutical, medical, healthcare, and life
sciences information and analysis; downloadable electronic
publications in the nature of brochures, reports and white
papers in the pharmaceutical, medical, healthcare and life
sciences fields; computer software, mobile applications and
instructional manuals in electronic format sold as a unit
therewith, for use in data collection, data management and
data analysis of pharmaceutical, medical, healthcare, and
life sciences information; computer software, mobile
applications and instruction manuals in electronic format
sold as a unit therewith, for healthcare management, namely,
patient, prescriber, payor and employee management;
electronic database recorded on computer media containing
pharmaceutical, medical, healthcare, and life sciences
information; computer software for collecting, managing, and
analyzing clinical trial data and information in the
pharmaceutical, medical, healthcare and life sciences
fields; computer hardware and software for healthcare
management and electronic health record (EHR) management;
computer software for collecting, managing, and analyzing
data related to patient registries, quality improvement,
patient support, and patient management in the
pharmaceutical, medical, healthcare, and life sciences
fields
35
Market analysis and research services; business market
consulting; marketing consulting; business consulting and
information services; business consulting services and
business management consulting in the pharmaceutical,
medical, healthcare, and life sciences fields; business
process outsourcing services in the pharmaceutical, medical,
healthcare, and life sciences fields; business research,
namely, public policy research services; marketing research,
namely, public policy research services; business research,
namely, public policy research services in the field of
healthcare; computerized database management and data
processing services in the pharmaceutical, medical,
healthcare, and life sciences fields; sales representatives
in the pharmaceutical, medical, healthcare, and life
sciences fields; business consultation and management
regarding marketing activities, launching of new products
and services, and sales; personnel recruitment and
placement; business consulting and management in the field
of clinical trials, namely, clinical data and regulatory
submission management on behalf of pharmaceutical, medical,
healthcare, and life sciences companies to assist them with
clinical research, clinical trials and applications for
drug, biologic and device approval; providing independent
review of clinical trials for business purposes; maintaining
a registry of patients, namely, compilation of patient
information into computer databases; business consulting and
business management consultation services related to
healthcare management and electronic health records (EHR)
management; business management consulting and advisory
services in pharmaceutical, medical, healthcare, and life
sciences fields; advertising, marketing and promotional
services in the pharmaceutical, medical, healthcare, and
life sciences fields; business management services, namely,
quality management services for establishing business
quality policies for patient- care programs; recruitment
services, namely, advertising clinical trials, recruiting
patients, and placing patients for participation in clinical
trials for testing of drugs, biologics and devices; business
consulting in the fields of healthcare management
41
Education and training services, namely, conducting training
programs, seminars, classes, conferences and workshops in
the pharmaceutical, medical, healthcare, and life sciences
fields; educational and training services, namely,
conducting conferences to train physicians and other medical
providers on conducting clinical trials; providing education
and training services through non-downloadable webinars,
webcasts and digital content in the form of podcasts in the
pharmaceutical, medical, healthcare, and life sciences
fields; providing non-downloadable online publications in
the nature of brochures, reports, or white papers in the
pharmaceutical, medical, healthcare, and life sciences
fields; medical evaluation and education services, namely,
education in the form of individual training and classes for
training of patients, physicians and other healthcare
providers on disease and treatment management
42
Providing online, non-downloadable software providing
pharmaceutical, medical, healthcare, and life sciences
information and analysis; software as a service (saas)
services featuring software providing, collecting, analyzing
pharmaceutical, medical, healthcare, and life sciences
information; computer services, namely, providing on-line,
non-downloadable computer software used for accessing,
collecting, managing, tracking, analyzing, and reporting
data in the pharmaceutical, medical, healthcare, and life
sciences fields; research related to pharmaceutical,
medical, healthcare, and life sciences information; computer
services, namely, designing, developing and maintaining
application software; computer services, namely, designing
and developing databases related to pharmaceutical, medical,
healthcare, and life sciences information; computer software
development for others; clinical research, clinical testing,
and laboratory testing services in the pharmaceutical,
medical, healthcare, and life sciences fields; product
development consultation in the pharmaceutical, medical,
healthcare, medical and life sciences fields; conducting
clinical trials for others; providing temporary use of
on-line non-downloadable software for use in healthcare and
electronic health record (EHR) management; information
technology consulting services; computer software
consultation services in the pharmaceutical, medical,
healthcare, and life sciences fields; scientific research in
the pharmaceutical, medical, healthcare, and life sciences
fields; computer services, namely, creating computer
network- based indexes and databases of information;
providing electronic data capture and data management
systems, namely, providing temporary use of online,
non-downloadable software for collection and management of
healthcare and life sciences data; providing temporary use
of online, non- downloadable computer software for
collecting, managing, and analyzing clinical trial data;
providing scientific information in the pharmaceutical,
medical, healthcare, and life sciences fields, through an
on-line interactive database; providing scientific
information relating to the development, validation, and
regulatory approval of pharmaceutical drugs, biologics, and
medical devices; hosting a web-based online portal that
provides customer access to business information in the
pharmaceutical, medical, healthcare, and life sciences
fields; computer services, namely, maintaining databases
related to pharmaceutical, medical, healthcare, and life
sciences information
44
Providing health, medical, pharmaceutical, health management
and disease management information to others
45
Regulatory compliance legal research in the field of
development of drugs, devices, biologics and methodologies
used in the pharmaceutical industry, and medical industry;
regulatory compliance consulting in the pharmaceutical,
medical, healthcare, and life sciences fields; providing
regulatory information, namely, legal information regarding
compliance with pharmaceutical, medical, healthcare, and
life sciences regulations; providing regulatory
implementation services, namely, regulatory compliance
consulting, in the fields of the development, validation,
and production of drugs, biologics and devices; providing an
online, interactive computer database in the field of
regulatory affairs relating to the pharmaceutical, medical,
healthcare, and life sciences fields (terms considered too
vague by the International Bureau – Rule 13 (2) (b) of the
Common Regulations)
Die Bezeichnungen wurden automatisch übersetzt. Übersetzung anzeigen
Markenhistorie
| Datum | Belegnummer | Bereich | Eintrag |
|---|---|---|---|
| 18. Oktober 2021 | 2021/43 Gaz | CN | RAW: Rule 18ter(4) protected goods and services |
| 11. Dezember 2020 | 2021/2 Gaz | MX | RAW: Rule 18ter(2)(ii) GP following a provisional refusal |
| 15. Mai 2020 | 2020/33 Gaz | ZW | Ablehnung |
| 06. Februar 2020 | 2020/7 Gaz | JP | RAW: Rule 18ter(2)(ii) GP following a provisional refusal |
| 05. Februar 2020 | 2020/7 Gaz | AU | RAW: Rule 18ter(2)(ii) GP following a provisional refusal |
| 30. Januar 2020 | 2020/9 Gaz | CH | RAW: Rule 18ter(2)(ii) GP following a provisional refusal |
| 21. Januar 2020 | 2020/4 Gaz | KR | RAW: Rule 18ter(2)(ii) GP following a provisional refusal |
| 16. Januar 2020 | 2020/6 Gaz | SG | RAW: Rule 18ter(2)(ii) GP following a provisional refusal |
| 03. Dezember 2019 | 2019/49 Gaz | NZ | RAW: Rule 18ter(2)(ii) GP following a provisional refusal |
| 18. Oktober 2019 | 2019/43 Gaz | NO | RAW: Rule 18ter(2)(ii) GP following a provisional refusal |
| 03. September 2019 | 2019/37 Gaz | IL | RAW: Rule 18ter(2)(i) GP following a provisional refusal |
| 15. August 2019 | 2019/33 Gaz | UA | Ablehnung |
| 07. August 2019 | 2019/33 Gaz | EM | RAW: Rule 18ter(2)(i) GP following a provisional refusal |
| 06. August 2019 | 2019/32 Gaz | VN | Ablehnung |
| 01. August 2019 | 2019/31 Gaz | JP | Ablehnung |
| 11. Juli 2019 | 2019/29 Gaz | CH | Ablehnung |
| 30. Mai 2019 | 2019/23 Gaz | PH | RAW: Rule 18ter(2)(i) GP following a provisional refusal |
| 15. Mai 2019 | 2019/20 Gaz | CO | Ablehnung |
| 08. Mai 2019 | 2019/19 Gaz | MX | Ablehnung |
| 30. April 2019 | 2019/18 Gaz | TR | Ablehnung |
| 16. April 2019 | 2019/17 Gaz | NO | Ablehnung |
| 09. April 2019 | 2019/15 Gaz | RS | Ablehnung |
| 04. April 2019 | 2019/15 Gaz | KR | Ablehnung |
| 25. März 2019 | 2019/13 Gaz | IN | Ablehnung |
| 19. Februar 2019 | 2019/9 Gaz | RU | Ablehnung |
| 12. Februar 2019 | 2019/15 Gaz | AU | Ablehnung |
| 31. Januar 2019 | 2019/6 Gaz | EM | Ablehnung |
| 22. Januar 2019 | 2019/9 Gaz | CN | Ablehnung |
| 28. November 2018 | 2018/50 Gaz | IL | Ablehnung |
| 22. November 2018 | 2018/48 Gaz | SG | Ablehnung |
| 03. Oktober 2018 | 2018/41 Gaz | PH | Ablehnung |
| 13. September 2018 | 2018/39 Gaz | NZ | Ablehnung |
| 02. Oktober 2017 | 2018/32 Gaz | US | Eintragung |
ID: 141419544